Novel selective medium for isolation of Burkholderia pseudomallei by Howard, K. & Inglis, T.J.J.
 
MURDOCH RESEARCH REPOSITORY 
http://researchrepository.murdoch.edu.au 
This is the author's final version of the work, as accepted for publication following peer review but without the 
publisher's layout or pagination. 
Howard, K. and Inglis, T.J.J. (2003) Novel Selective Medium for Isolation of Burkholderia pseudomallei. 
Journal of Clinical Microbiology, 41 (7). pp. 3312-3316. 
http://researchrepository.murdoch.edu.au/3309 
Copyright © 2003, American Society for Microbiology 
It is posted here for your personal use. No further distribution is permitted.   1 
Novel selective medium for the isolation of Burkholderia pseudomallei  
K. Howard and T.J.J. Inglis 
Division of Microbiology and Infectious Diseases, Western Australian Centre for 
Pathology and Medical Research 
 
  Correspondence: 
Dr K Howard, Division of Microbiology and Infectious Diseases, Western Australian 
Centre for Pathology and Medical Research (PathCentre), Locked Bag 2009, 
Nedlands WA  6909, AUSTRALIA. 
  Phone:  +618 9346 3640 
  Fax:    +618 9381 7139 
  Email:  khoward@cyllene.uwa.edu.au 
 
  Keywords:  Burkholderia pseudomallei, agar, medium   2 
SUMMARY 
   For many years laboratory isolation of Burkholderia pseudomallei, the cause of the 
potentially fatal infection melioidosis, has relied on the use of Ashdown’s selective agar 
(ASA).  It has become apparent recently that ASA inhibits growth of some clinical isolates.  
We designed a new selective agar (Burkholderia pseudomallei selective agar; BPSA) to 
improve recovery of the more easily inhibited strains of B. pseudomallei and describe here the 
laboratory evaluation of that medium.  Fifty strains of B. pseudomallei, 11 strains of 
B. cepacia, 51 strains of Pseudomonas aeruginosa and strains of other bacterial genera were 
used to determine the selectivity and sensitivity of BPSA.  Most strains of B. pseudomallei 
produced larger colonies on BPSA than on ASA at 24 h.  BPSA inhibited 4 of 11 strains of 
Burkholderia cepacia which all grew on ASA.  BPSA should make recognition of Burkholderia 
species easier due to distinctive colony morphology.  BPSA was also more inhibitory to 
P. aeruginosa than ASA.   BPSA inhibited representative type strains of other bacterial 
species (Enterococcus faecalis, Escherichia coli, Staphylococcus aureus and Streptococcus 
pyogenes).  These results indicate that BPSA is a potential replacement for ASA.  Use of 
BPSA in clinical diagnostic laboratories may confirm the anticipated high prevalence of 
undiagnosed subacute melioidosis in the main endemic areas of Northern Australia and 
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   Laboratory diagnosis of acute septicaemic melioidosis is usually made by conventional 
blood culture techniques.  In these circumstances a rich non-selective agar is adequate (7).  
However, isolation of Burkholderia pseudomallei is more difficult in clinical specimens from 
non-sterile body sites.  Isolation from sputum is particularly difficult when low numbers of 
B. pseudomallei are present and there is an abundant commensal upper respiratory flora.  
The isolation of other non-fermentative Gram negative species that morphologically resemble 
B. pseudomallei further compounds the difficulties experienced in the bacteriological 
diagnosis of melioidosis (5).   
   Ashdown’s selective agar (ASA; 1) is the currently favoured medium for the isolation and 
presumptive identification of B. pseudomallei in melioidosis-endemic areas. B. pseudomallei 
produces highly wrinkled circular purple colonies on ASA by 48 h.  A report of 
B. pseudomallei detection by rtPCR despite an absence of growth on ASA (2) suggests that 
significant improvements could be made to the isolation technique currently in use.  It has 
also been noted in local clinical laboratory use that ASA is inhibitory to some strains of B. 
pseudomallei (6).  In that study, comparisons of ASA with a non-selective, enriched agar 
medium indicated that the recovery of the persistently mucoid variant could be improved. 
   There has been no significant improvement in the isolation of B. pseudomallei from clinical 
specimens from non-sterile sites since the original development of ASA.  The aim of the 
present study was to develop a selective agar (BPSA; Burkholderia pseudomallei selective 
agar) that did not inhibit the persistently mucoid colony form of B. pseudomallei while 
maintaining selective activity against other bacteria. 
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   Media development.  Each of the ingredients of Ashdown’s selective medium (trypticase 
peptone, 4% glycerol, 5 mg/L crystal violet, 50 mg/L neutral red and 4 mg/L gentamicin), nile 
blue and 9 potential carbon sources were tested for inhibition of colony formation, colony size 
and wrinkling of colony surfaces by individual inclusion to a minimal media.  In preliminary 
studies nile blue proved to be an effective antibacterial supplement (6). 
   Primary carbon source.  B. pseudomallei strains NCTC 13177 and BCC11, representative 
of non-mucoid and mucoid colony forms, respectively, three strains of B. cepacia (NCTC 
10743, NCTC 10661 and WACC1185) and one strain of Pseudomonas aeruginosa were used 
to determine the optimum carbon source for the growth of all colony forms of B. pseudomallei 
while being deleterious to potential competitors.  200 or 20 mg/L of each C source (maltose, 
glycerol, D-(-)-β-hydroxybutyric acid, salicin, succinic acid, sodium salicylate, D(+)-
glucosamine, i-erythritol and isobutyric acid) was added to a minimal medium (K2HPO4 7 g/L, 
KH2PO4 2 g/L, (NH4)2SO4 1g/L, MgSO4 1 mL of 10 mg/mL).  The control medium for this 
experiment contained no C source.  Inoculum was prepared as 10 mL overnight cultures then 
centrifuged at 300 g for 15 min, the pellet was resuspended in 3 mL cold water for 10 min and 
centrifuged for a further 10 min.  This wash step was repeated and the pellet was 
resuspended in minimal media with no carbon source.  A 10 µL inoculation of approximately 
10
8 cfu/ml of each strain was put into 10 mL of pre-warmed (35°C) media.  There were two 
replicates for each treatment and 5 h colony counts and 24 h spectrophotometry readings 
(450 nm) were taken in duplicate to calculate growth in each medium. 
   The lower concentration of maltose provided the highest colony counts and largest colonies 
sizes of all C sources tested, while being slightly inhibitory to some B. cepacia strains. 
   Antibacterial supplements.  To determine if crystal violet, neutral red or nile blue are 
inhibitory to B. pseudomallei growth, 5, 100 and 20 mg/L of each, respectively, was added 
separately to standard methods agar (SMA) containing 2.67 mg/mL gentamicin.  Inoculum of 
the two type strains (NCTC 13177 and 10276) and the mucoid strain (BCC11) were prepared 
as for the carbon source experiment and suspensions of approximately 10
4 organisms/mL 
water were spiral plated (Don Whitley, Shipley, UK) onto three replicate plates for each 
treatment.  Colony counts were done at 24 h for each strain and at 48 h for the non-mucoid   5 
strains.  Three plates of each strain were streaked for single colonies and the largest colony 
on each plate was recorded at 24 and 48 h after incubation at 35°C. 
   Crystal violet reduced colony counts of NCTC 13177 by 100 fold and reduced colony sizes 
of NCTC 10276 by 75% and BCC11 by 50%.  Neutral red and nile blue had no effect on 
colony counts but slightly reduced the colony size of NCTC 13177. 
   Glycerol.  To test if the incorporation of glycerol into solid media had any effect on the 
persistently mucoid strain SMA was prepared with 0 and 4% glycerol.  Glycerol (0 and 4%) 
was also added to a less rich medium (K2HPO4 1.7 g/L, KH2PO4 0.45 g/L, MgSO4.7H2O 0.12 
g/L, CaCl2 0.01 g/L, NaCl 10g/L) solidified with 1% bacteriological agar (Oxoid Ltd., London).  
The glycerol was added after autoclaving when the medium had cooled to 40°C.  Inoculum 
was grown overnight, washed and diluted to approximately 10
3 organisms/mL, before spiral 
plating onto the test medium.  Colony counts were done at 24 and 48 h after incubation.   
   Addition of glycerol to SMA had no significant effect on colony counts, however it 
significantly reduced colony size.  The colonies were slower to appear and were very small 
(<0.1 mm) on the minimal media containing glycerol. 
   BPSA preparation.  BPSA comprised 23.5 g standard methods agar (BBL, USA), 4 g 
maltose (Sigma, St Louis, USA) and 100 mg neutral red (Sigma, St Louis, USA) in 1 L 
distilled water, sterilised at 134°C for 10 min (or 121°C for 15 min).  The agar was allowed to 
cool to 40-45°C, then 20 mg/mL gentamicin (Sigma, St Louis, USA) and 1 mL of 20 g/L nile 
blue (dissolved in 1% DMSO) were added after filter sterilisation via a 0.8/0.2 µm membrane 
(Pall Corporation, MI, USA).  Ten mL of glycerol (equivalent to 1%) (BDH, Merck P/L 
Australia) was added and the media placed onto a heated magnetic stirrer at 40°C for 5 min 
before plates were poured (18 mL/plate).  ASA plates were prepared by Excel Laboratory 
Products, Western Australia, and included batch numbers 213164, 214750, 216753 and 
220269.   
   Bacterial strains used to evaluate BPSA.  The following strains were used:  
B. pseudomallei reference strains NCTC 10276, NCTC 13177, and 48 wild strains from 
clinical and environmental isolations, which included the persistently mucoid variant 
WACC11; 11B. cepacia wild strains representative of each genomovar (T. Pitt, PHLS, 
Colindale, UK); 51 wild strains of P. aeruginosa and one wild strain each of P. fluorescens,   6 
P. pseudoalcaligenes, P. putida and P. stutzeri, 1 isolate each of Staphylococcus aureus 
(ATCC 25923), Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC 25922) and 
Streptococcus pyogenes (ATCC 19615).   
   All strains were taken from 15% glycerol in brain heart infusion broth stock kept at –70°C 
and plated onto blood agar (BA) for a maximum of 3 d, then transferred to 10 mL trypticase 
soy broth (TSB) for 18 h incubation prior to use in the experiments.  All incubations were in air 
at 35°C.  Apart from 5 strains recently isolated, all strains had been stored for over 6 months 
prior to commencement of the present study.   
   Glycerol in BPSA.  To examine the effect of glycerol on the surface wrinkling of colonies 
concentrations of 0, 1, 3, and 4 % (v/v) was added to BPSA.  Three plates of each glycerol 
concentration were streaked for single colonies with NCTC 13177 and 10276, and BCC11.  
Wrinkling was ranked using the system shown in Table 1 at 48 h and 7 days. 
   At 48 h there was no wrinkling in strain 10276, but increasing glycerol concentration 
increased wrinkling in strain 13177.  Both these non-mucoid strains had colonies that were 
non-reflective at 96 h, and wrinkling was ranked as 4 at all concentrations. 
   At 48 h the mucoid strain, BCC11, had smooth convex colonies at all glycerol 
concentrations.  By 96 h the highest rank for wrinkling (2) was produced on the media with the 
lowest concentration of glycerol (1%) while at highest concentration the rank remained 0.  By 
7 days, the mucoid strain produced only one large wrinkle per colony on the highest 
concentration of glycerol.   
EVALUATION OF SELECTIVE MEDIA 
   Burkholderia species.  30 clinical and 20 environmental strains of B. pseudomallei and 11 
strains of B. cepacia were used to compare the sensitivity of BPSA with ASA.  Overnight 
cultures of each strain were washed and diluted to a 10
4 cfu/mL suspension and the plates 
were inoculated using a spiral plater.  There were 3 replicates of each strain on BPSA and 
ASA, with the lower limits of detection being 2.0 x 10
1 cfu/mL.  Colony forming units were 
counted at 24 and 48 h.  A further 3 plates each of BPSA and ASA were inoculated to 
produce single colony growth of each B. pseudomallei strain.  The largest colonies on each 
plate were measured at 1.5x magnification after 24 and 48 h incubation, and then measured 
again after 7 d.  The colony counts and radial growth measurements on the two media were   7 
compared using paired t tests.  The macroscopic appearance of the single colonies, including 
wrinkling of the colony surface, was observed at each of these time points.  The degree of 
colony wrinkling was assessed using a ranking system (Table 1).  This experiment was 
repeated once. 
   B. pseudomallei.  Colony counts of the type strains of B. pseudomallei on BPSA were 
comparable (p=0.85) with those on ASA while the persistently mucoid strain produced a 
significantly (p<0.05) higher count on BPSA (Figure 1).  On BPSA, 98% of B. pseudomallei 
strains produced equivalent or higher colony counts (p=0.05) than on ASA (Table 2).  The 
exception was one clinical strain at 48 h.  At 24 h, 7 clinical strains had not grown on ASA but 
produced counts of 10
4 organisms/mL on BPSA.  The difference between the two media was 
reduced after 48 h incubation.   
   The other most notable difference between BPSA and ASA was the significant increase 
(p<0.05) in colony size of 36% of B. pseudomallei strains on BPSA.  All 50 strains produced 
larger colonies on BPSA after 24 h incubation, with 86% of strains being 2 to 9 times larger.  
Of the 3 mucoid strains examined, 2 produced 25% larger colonies on BPSA.  The difference 
in colony size on the two selective media decreased with time so that by 7 d only 60% of 
colonies were at least 10% larger on BPSA than on ASA.   
   One recently isolated clinical strain showed significantly (p<0.05) more wrinkling on BPSA 
after 7 d.  On ASA this strain did not wrinkle but presented as a convex smooth colony 
(ranked as 0), while on BPSA it produced contours and some wrinkling (ranked as 3).  While 
there was no significant difference overall in the amount of wrinkling between colonies on 
each medium at 48 h, one quarter of the strains was more wrinkled on BPSA than on ASA.   
This reflected a generally faster growth of colonies on BPSA. 
   Whilst a variety of surface wrinkling patterns was observed on BPSA, all non-mucoid strains 
produced a characteristic flat and dry, mauve coloured colony by 48 h.  These colonies 
progressed over 7 d to become deep purple and highly wrinkled (Figure 2a and b).  The 
exception to this was the one strain that only grew sparsely on ASA.  This strain had distinct 
colonies that remained convex and absorbed little of the red pigment.  Colonies of this strain 
were pink, circular and lobate after 7 d.  The persistently mucoid strain produced large wet 
colonies that had a blue/purple border and a pink to mauve centre (Figure 2c).  Under UV   8 
illumination non-mucoid strains of B. pseudomallei produced yellow fluorescent colonies on 
BPSA.  Fluorescence was fainter in mucoid colonies.  Colonies grown on ASA did not 
fluoresce. 
   B. cepacia.  Four of the eleven strains of B. cepacia (from genomovar I, II and III) were 
significantly (t= 1.81; p=0.009) inhibited on BPSA compared to their growth on ASA at 24 and 
48 h.  One strain of genomovar I was totally inhibited compared to growth on ASA.  At 24 h, 
four strains had larger colonies on ASA than on BPSA, while 3 strains grew slightly larger on 
BPSA than on ASA.   
   In contrast to B. pseudomallei, colonies of B. cepacia did not wrinkle on BPSA.  On this 
medium, B. cepacia formed circular, convex, transparent colonies with an entire edge by 24 h, 
and turned to a translucent pink colour at 48 h.  By 7 d B. cepacia produced opaque and dark 
pink convex, lobed colonies.  Seven strains of B. cepacia produced a similar fluorescence to 
B. pseudomallei under UV light.  There was no fluorescence detected from the remaining four 
strains, which included both representatives of genomovar II.    
    Pseudomonas species and other genera of clinical importance.  To assess the 
selectivity of BPSA, overnight cultures of 51 strains of Pseudomonas aeruginosa and 10 other 
clinical species (Escherichia coli, Enterococcus faecalis, Pseudomonas alcaligenes, 
P. fluorescens, P. oryzihabitans, P. pseudoalcaligenes, P. putida, P. stutzeri, Staphylococcus 
aureus and Streptococcus pyogenes) were prepared from overnight cultures.  Three 10 µL 
aliquots of a 0.5 McFarland’s bacterial suspension were dropped onto two replicate plates of 
SMA, ASA and BPSA.  Growth of colonies from these drops was recorded for the three media 
as present, absent or scanty at 24 and 48 h.  Scanty  growth was recorded when less than 3 
colonies grew per inoculation or the colonies remained smaller than 1 mm.  All bacteria tested 
grew on SMA within 24 h. 
   P. aeruginosa was significantly (χ
2 = 43.09; p < 0.0001) inhibited on BPSA.  Only 36% of 
strains grew by 48 h compared with 96% on ASA.  All 51 strains grew on the SMA control 
plates within 24 h.  All strains examined under UV fluoresced blue on BPSA.        
      While ASA proved to be more selective, the growth of Staphylococcus aureus and 
P. fluorescens, P. pseudoalcaligines and P. oryzihabitans on BPSA was scant and did not 
appear until 48 h after inoculation (Table 2).  There was a 9 log10 decrease in colony counts of   9 
gentamicin resistant P. aeruginosa and S. aureus on all selective media used.  On BPSA the 
P. aeruginosa strains fluoresced blue under UV illumination, while E. faecalis, E. coli, S. 
pyogenes and S. aureus did not fluoresce. 
  
   In conclusion, this evaluation of selective media for the isolation of B. pseudomallei showed 
the novel medium BPSA was better than Ashdown’s selective agar medium.  The 
improvements included a reduced time to detection by increased numbers of colonies and 
larger colony size, and the recovery of strains of B. pseudomallei inhibited by ASA.   
   Although ASA performs well as a selective agar it inhibits persistently mucoid strains of 
B. pseudomallei.  It was previously noted that rough strains of B. pseudomallei grew on 
glycerol agar but this medium was inhibitory to the smooth strain (8).  In 2 out of the 3 mucoid 
strains tested, BPSA produced larger colonies faster.  As glycerol is a precursor for 
polyhydroxybutyrate synthesis, it is required in BPSA but less glycerol was incorporated than 
is in ASA.  Crystal violet, which was inhibitory to mucoid strains, was excluded from BSPA.  
The isolation of mucoid variant strains from clinical specimens is uncommon at present, 
however, this may reflect the inhibitory effect of ASA on B. pseudomallei in non-sterile sites.  
The only persistently mucoid strains isolated to date in Australia have been recovered on non-
selective agar in clinical diagnostic use.   
   BPSA was highly selective against a variety of Gram positive and Gram negative bacterial 
species.  Pseudomonas species, including some gentamicin resistant strains of 
P. aeruginosa, were inhibited on BPSA.  This is a feature that is expected to prove useful in 
inhibiting growth of P. aeruginosa commonly found as a contaminant in sputum specimens.  
There was moderate improvement in the inhibition of B. cepacia on BPSA from the 
genomovar collection tested.  The combined inhibitory effect on bacterial species closely 
related to B. pseudomallei will assist the diagnostic laboratory by reducing the number of 
isolates that might otherwise be misidentified as B. pseudomallei.  While a absence of 
wrinkling may be a key to the differentiation between B. cepacia and B. pseudomallei there is 
still a need for further confirmatory tests such as PCR.   
   Diagnostic laboratories have come to depend on wrinkling as a morphological identification 
feature.  BPSA provides larger wrinkled colonies, faster than ASA.  This means that   10 
B. pseudomallei colonies are more visible and there is more bacterial growth for 
supplementary tests.  This is particularly important in melioidosis where public health control 
strategies that rely on rapid isolation of B. pseudomallei will also benefit from faster detection.  
This time reduction should also improve the quality of antibiotic treatment for patients.  While 
public health investigations of melioidosis are hampered at present by delays in isolation of 
B. pseudomallei from non-sterile clinical sites, isolation of B. pseudomallei from environmental 
specimens such as soil and water takes even longer (3, 4).  Given the current interest in a 
rapid public health response to a suspected deliberate biohazard release, there is a pressing 
need for an improved B. pseudomallei selective agar such as the novel medium we describe 
here. 
   Utilising the above mentioned morphological features including UV fluorescence and colour 
of colonies means that less manipulation of suspect organisms is necessary in preliminary 
work.  This should reduce exposure to aerosols of B. pseudomallei, which are known to have 
caused laboratory acquired infection on at least two occasions (9).     
   The manufacture of BPSA is possible even in smaller clinical laboratories throughout the 
endemic region.  Preliminary assessments indicate that shelf life is 8 weeks at 4°C.  A more 
detailed evaluation of BPSA for the clinical diagnosis of melioidosis is now required.   
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Table 1.  Ranking system for surface wrinkling of single colonies of Burkholderia 
pseudomallei grown on solid media. 
Rank  Colony surface description 
0  No wrinkling  - a smooth colony surface 
1  Single concentric undulation or contour 
2  Radial ridges within a single concentric contour  
3  Radial ridges within and beyond the single concentric contour 
4  Additional striations on radial ridges within and beyond concentric 
contour 
   13 
Table 2.    Growth (+), scanty growth (+/-) or no growth (-) of clinical strains and type strains of 
bacterial colonies at 48 h on Ashdown’s selective agar (ASA) and Burkholderia pseudomallei 
selective agar (BPSA). 
 
Bacterial species  Culture 
identification 
ASA  BPSA 
Escherichia coli  ATCC 25922  -  - 
Enterococcus faecalis  ATCC 29212  -  - 
Staphylococcus aureus  ATCC 25923  +/-  +/- 
Streptococcus pyogenes  ATCC 19615  -  - 
Pseudomonas alcaligenes  SSCC 18997  -  - 
P. fluorescens  SSCC 15298  -  +/- 
P. oryzihabitans  SSCC 17895  -  +/- 
P. pseudoalcaligenes*  SSCC 17344  -  +/-  
P. putida  SSCC 17676  +/-    - 
P. stutzeri  SSCC 15643  -  - 
* Gentamicin resistant 
ATCC is the American Type Culture Collection 
SSCC is the Sterile Site Culture Collection, PathCentre, Western Australia 

















Figure 1.  Colony counts of Burkholderia pseudomallei strains after 48 h incubation on 
  Ashdown’s selective agar (Ashdown, 1979) and    BPSA (Burkholderia pseudomallei 
selective agar).   15 
 
 
Figure 2.  Colony morphology at 48 h (left) and 7 d (right) of Burkholderia pseudomallei  on 
B. pseudomallei selective media (BPSA).  a) type strain NCTC 13177,  b) type strain NCTC 
10276, and c) the persistently mucoid strain WACC11.  Bar = 1 mm. 